Postdoc position in dendritic cell and cross-presentation biology - four days left to apply: https://t.co/WjBuXT7KIQ Join our team to work on these coolest cells ever! 🥰

I’m very proud of my postdoc Helen Mostafavi who just gave a great talk on endothelial dysfunction in SARS-Cov-2 @options2024. It’s been a great collaboration with @VesselDynamics and @KengYih and @K_RenfreeShort

@TheWellsLab @HendersonLab

I'm very proud to have co-authored this review on antibodies and infection with my twitterless PhD student Tyron Esposito, @TheWellsLab and @HendersonLab. Please check it out 👇 Mechanisms of antibody-dependent enhancement of infectious disease | Nature Reviews Immunology

Interested in Caspase and LPS signalling? Looking for a multidisciplinary position with a bit of immunology, biochemistry and host-pathogen interactions? Look no further! Our lab is recruiting a second PDRA funded by @BBSRC. See details below

Hi everyone! I’m on the lookout for a new role and would really appreciate your support. I'm particularly interested in chatting with #pharma, #biotech and #CROs about how my #biomedical #research skills may benefit your team. I am based in Brisbane, Australia.

Highly recommend Rinie!

How’s your abstract looking for OptionsXII? April 5th coming up…Join the School of Influenza before the main conference kickoff to become FLU-ENT in all things Flu related

Options 2024! Are you ready! Submit your abstract by April 5th in these categories https://t.co/Wqj1dcEFd7 so you can visit this amazing place… Brisbane https://t.co/oLxzVJPqR4 or sneak off to https://t.co/7Eg70jEIEU Amidst amazing research in flu, COVID and RSV

PhD projects available now for a 2024 START. Studying virus: host interactions working on African swine fever virus or Japanese encephalitis using novel tools( inc. multiomics and ex vivo models ) to understand pathogenesis with impact @CSIRO Job link in comments

It's finally out! Well-done to @amy_chancan and many others from @inflammasomelab! Caspase-4 dimerisation and D289 auto-processing elicit an interleukin-1β-converting enzyme

Many extraordinary, life changing inventions have come from 🇦🇺 From the bionic ear to wifi. But they won't keep happening if we don't fund research. Federal research investment has ⬇️ to record lows. This budget is an opportunity to change that. https://t.co/RKrGFnbp3i

Extremely happy to share our latest publication. Another fantastic study from the outstanding Dr @katebalka! What a PhD from this superstar! @MonashBDI @embojournal Enjoy!👍 Termination of STING responses is mediated via ESCRT‐dependent degradation

A big shoutout to the @IMBatUQ imaging and microscopy experts @Lagendijk_lab @VesselDynamics @LabParton @JamesRa91582693 because seeing is believing. And of course to @SarahLondrigan and @inflammasomelab for their outstanding leadership and support.

Huge thanks to all of the people who contributed to this project including my fantastic (twitterless) lab Xiaohui Wang and Tyron Esposito and Kathrin Eschke, and @KengYih @claudiajades @brittanyhill__ @CarolineLHolley @S_Emming @FritzlarSvenja @nefzgerc @K_RenfreeShort

Our study sheds light on how our favourite innate immune sentinel cells trigger inflammation and control virus infections.

We think all of those ACE2-neg macrophages will instead respond to neighbouring infected cells – like @katbarnett3, @ting_lab_unc found in COVID-19 https://t.co/zo4Ox6ssVn,

These ACE2-pos macs CAN make new infectious virions, BUT, all those anti-viral cytokines the macs make stop new virion release. If we block cytokine induction with a TBK1 inhibitor (BX795) then we rescue ACE2-pos mac virus production.

But SARS-CoV-2 can enter ACE2-pos macs (maybe even fuse at the plasma membrane) AND trigger macrophage cytokine release.